James McClory

Title: James McClory: Innovator in Antibody Library Technology

Introduction

James McClory is a notable inventor based in Belfast Antrim, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. His innovative work has the potential to enhance the efficiency of antibody binding and improve therapeutic outcomes.

Latest Patents

James McClory holds a patent for an "Antibody library and method." This patent discloses methods for generating antibody libraries, producing variant antibodies, and improving antibody binding through affinity maturation assays. The invention involves utilizing the nucleotide sequence of a target antibody to identify motifs recognized by deamination somatic hypermutation enzymes. By creating a small library of variants that incorporate these mutations, a higher proportion of variants with increased affinity can be generated. This technique has been demonstrated on trastuzumab and Cathepsin S antibodies, showcasing its effectiveness.

Career Highlights

James McClory is associated with Fusion Antibodies Limited, where he applies his expertise in antibody technology. His work has contributed to advancements in the field, particularly in the generation of high-affinity antibodies. His innovative approach to antibody library creation is paving the way for new therapeutic developments.

Collaborations

James has collaborated with notable colleagues, including Richard John Buick and Christopher Scott. These collaborations have further enriched his research and development efforts in the biotechnology sector.

Conclusion

James McClory's contributions to antibody library technology exemplify the innovative spirit of modern biotechnology. His patent and work at Fusion Antibodies Limited highlight the importance of advancements in this field.